Compare GeneDx Holdings Corp (WGS) vs XP Inc. Class A Common Stock (XP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs XP Inc. Class A Common Stock — how do they compare? GeneDx Holdings Corp trades at $67.6 (market cap $2.04B), while XP Inc. Class A Common Stock trades at $30.27 (market cap $14.99B). The key difference: XP Inc. Class A Common Stock is far larger — about 7.3× GeneDx Holdings Corp's market cap, and XP Inc. Class A Common Stock pays a 0.68% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold GeneDx Holdings Corp for 19 Days and XP Inc. Class A Common Stock for 0 Days on average.
| WGS | XP | |
|---|---|---|
Market Cap | $2.04B | $14.99B |
Volume | 659,215 | 14,273,752 |
Sector | Health | Financials |
52-Week High | $167.51 | $30.21 |
52-Week Low | $34.51 | $14.94 |
Typical Hold Time | 19 Days | 0 Days |
Enterprise Value | $2.08B | $24.70B |
Dividend Yield | — | 0.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GeneDx (WGS) trades at $68.53, down 4.18% today amid bearish technical signals despite recent positive earnings surprises. The stock shows mixed fundamentals with strong revenue growth to $454M in 2026 but negative profitability metrics including -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target representing 18% upside potential.
The investment case balances strong analyst support and genomic testing market growth against persistent profitability challenges and negative cash flow trends. Key catalysts include Q3 2026 earnings due soon and continued execution on operational improvements, while risks center on margin recovery timeline and competitive pressures in the rapidly evolving genomics space.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About XP Inc. Class A Common Stock
XP Inc. provides investment products and financial services in Brazil. Its platform includes brokerage, investment funds, fixed-income products, banking, insurance, and retirement solutions.
Read more on XP →
